HIV News and Research

RSS

Social support needed to reduce the barriers in accessing cardiac rehabilitation

Noted experts in cardiovascular rehabilitation attending the Third Jim Pattison-Mazankowski Alberta Heart Institute Cardiac Rehabilitation Symposium (Banff, April 21-23, 2023) observed that although cardiac rehabilitation benefits diverse groups of patients and affords the most cost-effective prevention for recurrent events, it is grossly underutilized globally.

28 Nov 2023

Towards a world free of tuberculosis: The ADVANCE-TB COST Action

Tuberculosis (TB) is caused by Mycobacterium tuberculosis. For decades, it has been among the top 10 reasons of death globally, and the number one infectious killer.

28 Nov 2023

Synthetic biologists develop versatile platform for targeted drug delivery

In recent years, cell and gene therapies have shown significant promise for treating cancer, cystic fibrosis, diabetes, heart disease, HIV/AIDS and other difficult-to-treat diseases.

27 Nov 2023

Study estimates hepatitis C infection seroprevalence in pregnant women

Researchers estimate the seroprevalence of hepatitis C virus in pregnant women globally and in World Health Organization-specific regions.

22 Nov 2023

Out for blood? For routine lab work, the hospital billed her $2,400

Reesha Ahmed was on cloud nine. It was January and Ahmed was at an OB-GYN's office near her home in Venus, Texas, for her first prenatal checkup.

21 Nov 2023

Breakthrough in HIV treatment: NMN shows promise in reducing CD4+ T cell activation

The impact of nicotinamide mononucleotide (NMN) on Clusters of differentiation 4+ (CD4+ ) Thymus cells (T cells) viz.

21 Nov 2023

Breakthroughs in TB prevention offer hope for children

Taking a common antibiotic could more than half the risk of children becoming sick with multidrug resistant tuberculosis (MDR-TB), according to findings presented this week at a conference on lung health.

20 Nov 2023

Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization

An interview with Kitty van Weezenbeek, Director of Surveillance, Prevention and Control of AMR for the World Health Organistion (WHO) AMR division.

20 Nov 2023

Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen

The TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline.

20 Nov 2023

CMA clarifies cooperation on combination therapies to speed up patient access to vital treatments

The Competition and Markets Authority (CMA) has today issued a statement clarifying that certain types of engagements between competing drug firms working on 'combination therapies' will not be prioritized for investigation - making it easier for drug firms to work together to develop vital treatments for use in the NHS.

17 Nov 2023

Grand Challenges Canada funding supports market introduction of dapivirine vaginal ring in Southern and East Africa

IPM South Africa NPC, an affiliate of the Population Council, has been issued a 15-month Transition to Scale Phase 2 award from Grand Challenges Canada to support the market introduction of the dapivirine vaginal ring (DapiRing) for women in Southern and East Africa.

16 Nov 2023

Curcumin boosts brain delivery of HIV drug, curbing inflammation and oxidative stress

Study shows curcumin enhances antiretroviral delivery and reduces inflammation and oxidative stress in HIV, offering potential improvements in treating HIV-associated neurocognitive disorders.

16 Nov 2023

Immune response that protects against infections also drives HIV latency

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.

15 Nov 2023

Cannabis shows promise in easing endometriosis pain, new research suggests

The Journal of Clinical Medicine review explores cannabis as a self-management strategy for endometriosis pain, revealing its potential to reduce gut inflammation and improve gut permeability, thereby alleviating bloating and suppressing pain through interactions with the endocannabinoid system and gut microbiota.

14 Nov 2023

COVID-19 pandemic slowed progress toward ending HIV epidemic in the U.S.

The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities, according to UC Francisco researchers leading the largest U.S. evaluation of the impact of the public health crisis on people with HIV.

14 Nov 2023

Study reveals mechanisms underlying non-suppressible HIV viremia

Human immunodeficiency virus (HIV) works by entering specific immune cells and replicating inside them.

14 Nov 2023

Study provides insights into longevity of neutralizing antibodies in HIV-1 infection

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people.

14 Nov 2023

Understanding factors influencing PrEP prescribing for adolescents

HIV pre-exposure prophylaxis (PrEP), a daily dose of two medications meant to prevent HIV infection in high-risk people, has changed public health dramatically in recent years.

14 Nov 2023

Do Republican spending cuts threaten federal HIV funding? For some programs, yes.

Republicans in Congress are "trying to wipe out federal funding to end the HIV epidemic."

14 Nov 2023

Young people begin to use nicotine through vaping rather than through cigarettes

Young adults are now more likely to vape than to use traditional cigarettes. After years of public health success in decreasing the numbers of people using cigarettes, researchers are seeing striking increases in the numbers of young people who use e-cigarettes regularly – so much so that, for the first time, there are more young people who begin to use nicotine through vaping rather than through cigarettes.

13 Nov 2023

HIV News and Research

Social support needed to reduce the barriers in accessing cardiac rehabilitation

Towards a world free of tuberculosis: The ADVANCE-TB COST Action

Synthetic biologists develop versatile platform for targeted drug delivery

Study estimates hepatitis C infection seroprevalence in pregnant women

Out for blood? For routine lab work, the hospital billed her $2,400

Breakthrough in HIV treatment: NMN shows promise in reducing CD4+ T cell activation

Breakthroughs in TB prevention offer hope for children

Uniting Against Antimicrobial Resistance: An Interview with the World Health Organization

Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen

CMA clarifies cooperation on combination therapies to speed up patient access to vital treatments

Grand Challenges Canada funding supports market introduction of dapivirine vaginal ring in Southern and East Africa

Curcumin boosts brain delivery of HIV drug, curbing inflammation and oxidative stress

Immune response that protects against infections also drives HIV latency

Cannabis shows promise in easing endometriosis pain, new research suggests

COVID-19 pandemic slowed progress toward ending HIV epidemic in the U.S.

Study reveals mechanisms underlying non-suppressible HIV viremia

Study provides insights into longevity of neutralizing antibodies in HIV-1 infection

Understanding factors influencing PrEP prescribing for adolescents

Do Republican spending cuts threaten federal HIV funding? For some programs, yes.

Young people begin to use nicotine through vaping rather than through cigarettes

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News